3-Deoxygalactosone, a new glucose degradation product in peritoneal dialysis fluids: Identification, quantification by HPLC/DAD/MSMS and its pathway of formation

Analytical and Bioanalytical Chemistry

Volumn 399, Issue 4, 2011, Pages 1689-1697

  Mittelmaier, Stefan ^a   Fünfrocken, Michael ^b   Fenn, Dominik ^b   Pischetsrieder, Monika ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b FRESENIUS MEDICAL CARE   (Germany)

Author keywords

3 Deoxygalactosone (3 DGal); alpha Dicarbonyl compounds; Glucose degradation products (GDPs); HPLC; Peritoneal dialysis fluid; Quinoxaline derivatives

Indexed keywords

3-DEOXYGALACTOSONE (3-DGAL); [ALPHA]-DICARBONYL COMPOUNDS; GLUCOSE DEGRADATION PRODUCTS (GDPS); HPLC; PERITONEAL DIALYSIS; QUINOXALINES;

BIOCOMPATIBILITY; CHROMATOGRAPHY; DEGRADATION; DIALYSIS; GLUCOSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

FLUIDS;

3 DEOXYGALACTOSONE; 3-DEOXYGALACTOSONE; DRUG DERIVATIVE; GALACTOSE;

ARTICLE; CHEMICAL STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; PERITONEAL DIALYSIS; SYNTHESIS; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GALACTOSE; MOLECULAR STRUCTURE; PERITONEAL DIALYSIS; TANDEM MASS SPECTROMETRY;

EID: 79451470967     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-010-4456-3     Document Type: Article

References (36)

1. JW Dobbie 1992 Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis Perit Dial Int 12 14 27 1:STN:280:DyaK387ot1Smtg%3D%3D
2. B Rippe O Simonsen O Heimbürger A Christensson B Haraldsson G Stelin L Weiss F-D Nielsen S Bro M Friedberg A Wieslander 2001 Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products Kidney Int 59 348 357 1:CAS:528:DC%2BD3MXot1yltQ%3D%3D 10.1046/j.1523-1755.2001. 00497.x (Pubitemid 32055244)
3. JD Williams N Topley KJ Craig RK Mackenzie M Pischetsrieder C Lage J Passlick-Deetjen 2004 The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane Kidney Int 66 408 418 10.1111/j.1523-1755.2004.00747.x (Pubitemid 38870119)
4. CB Nilsson-Thorell N Muscalu AH Andren PT Kjellstrand AP Wieslander 1993 Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes Perit Dial Int 13 208 213 1:STN:280:DyaK3sznvFSmtw%3D%3D
5. A Tauer T Knerr T Niwa TP Schaub C Lage J Passlick-Deetjen M Pischetsrieder 2001 In vitro formation of N[epsilon]-(carboxymethyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis Biochem Biophys Res Commun 280 1408 1414 1:CAS:528: DC%2BD3MXptlGjtg%3D%3D 10.1006/bbrc.2001.4294 (Pubitemid 32917803)
6. CG Schalkwijk N Posthuma HJ Brink PM Ter Wee T Teerlink 1999 Induction of 1, 2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids Perit Dial Int 19 325 333 1:STN:280:DyaK1MvjsFKksg%3D%3D
7. A Mahiout G Ehlerding R Brunkhorst 1996 Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients Nephrol Dial Transplant 11 2 6
8. M Nakayama Y Kawaguchi K Yamada T Hasegawa K Takazoe N Katoh H Hayakawa N Osaka H Yamamoto A Ogawa H Kubo T Shigematsu O Sakai S Horiuchi 1997 Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD Kidney Int 51 182 186 1:STN:280:DyaK2s7kvV2jtQ%3D%3D 10.1038/ki.1997.22
9. S Nakamura K Tobita T Tachikawa S Akamatsu Y Ohno A Kan M Katsuragawa K Yasumura S Miyazaki S Sakai T Morita Y Hirashawa T Niwa 2003 Immunohistochemical detection of an AGE, a ligand for macrophage receptor, in peritoneum of CAPD patients Kidney Int Suppl 84 S152 157 1:CAS:528:DC%2BD3sXjslCrsL0%3D 10.1046/j.1523-1755.63.s84.31.x
10. J Witowski TO Bender GM Gahl U Frei A Jorres 2001 Glucose degradation products and peritoneal membrane function Perit Dial Int 21 201 205 1:STN:280:DC%2BD3MvpsVOksw%3D%3D (Pubitemid 32447806)
11. LW Morgan A Wieslander M Davies T Horiuchi Y Ohta MJ Beavis KJ Craig JD Williams N Topley 2003 Glucose degradation products (GDP) retard remesothelialization independently of d-glucose concentration Kidney Int 64 1854 1866 1:CAS:528:DC%2BD3sXpsVCrtL8%3D 10.1046/j.1523-1755.2003.00265.x (Pubitemid 37323717)
12. T Tomo E Okabe T Yamamoto S Namoto T Iwashita K Matsuyama J Kadota M Nasu 2005 Synergistic cytotoxicity of acidity and 3, 4-dideoxyglucosone-3-ene under the existence of lactate in peritoneal dialysis fluid Ther Apher Dial 9 182 187 1:CAS:528:DC%2BD2MXlsFejtrY%3D 10.1111/j.1774-9987.2005.00228.x (Pubitemid 40734782)
13. D-H Lee S-Y Choi H-M Ryu C-D Kim S-H Park H-Y Chung I-S Kim Y-L Kim 2009 3, 4-Dideoxyglucosone-3-ene induces apoptosis in human peritoneal mesothelial cells Perit Dial Int 29 44 51 1:CAS:528:DC%2BD1MXjvFWksro%3D
14. T Linden B Musi L Järkelid G Forsbäck P Kjellstrand R Deppisch A Wieslander 2001 Glucose degradation products in peritoneal dialysis fluids may have both local and systemic effects: a study of residual fluid and mesothelial cells Perit Dial Int 21 607 610 1:STN:280:DC%2BD38%2FlslKntA%3D%3D
15. A Tauer TO Bender EH Fleischmann T Niwa A Jörres M Pischetsrieder 2005 Fate of the glucose degradation products 3-deoxyglucosone and glyoxal during peritoneal dialysis Mol Nutr Food Res 49 710 715 1:CAS:528: DC%2BD2MXos1Cntr4%3D 10.1002/mnfr.200400111 (Pubitemid 41008209)
16. JM Forbes ME Cooper MD Oldfield MC Thomas 2003 Role of advanced glycation end products in diabetic nephropathy J Am Soc Nephrol 14 S254 S258 1:CAS:528:DC%2BD3sXmslCqsLg%3D 10.1097/01.ASN.0000077413.41276.17
17. S-I Yamagishi Y Inagaki T Okamoto S Amano K Koga M Takeuchi 2003 Advanced glycation end products inhibit de novo protein synthesis and induce TGF-β overexpression in proximal tubular cells Kidney Int 63 464 473 1:CAS:528:DC%2BD3sXht1yrs7c%3D 10.1046/j.1523-1755.2003.00752.x (Pubitemid 36126793)
18. HY Lee HC Park BJ Seo JY Do SR Yun HY Song YH Kim YL Kim DJ Kim YS Kim C Ahn MJ Kim SK Shin 2005 Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (balance) Perit Dial Int 25 248 255
19. S Mortier D Faict NH Lameire AS Vriese 2005 Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model Kidney Int 67 1559 1565 1:CAS:528:DC%2BD2MXjsV2lsrw%3D 10.1111/j.1523-1755.2005.00237.x (Pubitemid 40463136)
20. T Linden G Forsback R Deppisch T Henle A Wieslander 1998 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis Perit Dial Int 18 290 293 1:STN:280:DyaK1czislShtA%3D%3D
21. T Linden A Cohen R Deppisch P Kjellstrand A Wieslander 2002 3, 4-Dideoxyglucosone-3-ene (3, 4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis Kidney Int 62 697 703 1:CAS:528: DC%2BD38Xmt1GlsLg%3D 10.1046/j.1523-1755.2002.00490.x (Pubitemid 34779784)
22. M Frischmann J Spitzer M Fünfrocken S Mittelmaier M Deckert T Fichert M Pischetsrieder 2009 Development and validation of an HPLC method to quantify 3, 4-dideoxyglucosone-3-ene in peritoneal dialysis fluids Biomed Chromatogr 23 843 851 1:CAS:528:DC%2BD1MXpt1Wlt74%3D 10.1002/bmc.1194
23. S Mittelmaier M Fünfrocken D Fenn T Fichert M Pischetsrieder 2010 Identification and quantification of the glucose degradation product glucosone in peritoneal dialysis fluids by HPLC/DAD/MSMS J Chromatogr B Anal Technol Biomed Life Sci 878 877 882 1:CAS:528:DC%2BC3cXjs1Olt7o%3D 10.1016/j.jchromb. 2010.02.004
24. J Witowski K Korybalska J Wisniewska A Breborowicz GM Gahl U Frei J Passlick-Deetjen A Jorres 2000 Effect of glucose degradation products on human peritoneal mesothelial cell function J Am Soc Nephrol 11 729 739 1:CAS:528:DC%2BD3cXisFertL0%3D
25. MA Madson MS Feather 1981 An improved preparation of 3-deoxy-erythro- hexos-2-ulose via the bis(benzoylhydrazone) and some related constitutional studies Carbohydr Res 94 183 191 1:CAS:528:DyaL3MXkvFyitL4%3D 10.1016/S0008-6215(00)80716-8
26. J Gobert MA Glomb 2009 Degradation of glucose: reinvestigation of reactive α-dicarbonyl compounds J Agric Food Chem 57 8591 8597 1:CAS:528:DC%2BD1MXhtVGkur7O 10.1021/jf9019085
27. E Marceau VA Yaylayan 2009 Profiling of α-dicarbonyl content of commercial honeys from different botanical origins: identification of 3, 4dideoxyglucoson-3-ene (3, 4-DGE) and related compounds J Agric Food Chem 57 10837 10844 1:CAS:528:DC%2BD1MXhtlegurzI 10.1021/jf903341t
28. YV Pfeifer LW Kroh 2010 Investigation of reactive α-dicarbonyl compounds generated from the Maillard reactions of l-methionine with reducing sugars via their stable quinoxaline derivatives J Agric Food Chem 58 8293 8299 1:CAS:528:DC%2BC3cXnvVehu7w%3D 10.1021/jf1008988
29. A Bravo JC Herrera E Scherer Y Ju-Nam H Rübsam J Madrid C Zufall R Rangel-Aldao 2008 Formation of alpha-dicarbonyl compounds in beer during storage of Pilsner J Agric Food Chem 56 4134 4144 1:CAS:528:DC%2BD1cXlslamsrw%3D 10.1021/jf703696p (Pubitemid 351967957)
30. M Hellwig J Degen T Henle 2010 3-Deoxygalactosone, a "new" 1, 2-dicarbonyl compound in milk products J Agric Food Chem 10.1021/jf102388v
31. EFLJ Anet 1964 3-Deoxyglycosuloses (3-deoxyglycosones) and the degradation of carbohydrates Adv Carbohydr Chem 19 181 218 1:CAS:528: DyaF2MXlvFWltQ%3D%3D
32. AP Wieslander R Deppisch E Svensson G Forsback R Speidel B Rippe 1995 In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis Perit Dial Int 15 158 164 1:STN:280:DyaK2Mzjslahsw%3D%3D
33. M Erixon A Wieslander T Linden O Carlsson G Forsback E Svensson JA Jonsson P Kjellstrand 2006 How to avoid glucose degradation products in peritoneal dialysis fluids Perit Dial Int 26 490 497 1:CAS:528: DC%2BD28XptFWrs7s%3D
34. T Zimmeck A Tauer M Fuenfrocken M Pischetsrieder 2002 How to reduce 3-deoxyglucosone and acetaldehyde in peritoneal dialysis fluids Perit Dial Int 22 350 356 1:CAS:528:DC%2BD3sXhtVyisbg%3D
35. M Krishnan P Tam G Wu A Breborowicz DG Oreopoulos 2005 Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: will new dialysis solutions prevent these changes? Int Urol Nephrol 37 409 418 1:CAS:528:DC%2BD2MXpvVSiurw%3D 10.1007/s11255-004-1392-1 (Pubitemid 41349211)
36. M Ahmad H Shah T Pliakogiannis D Oreopoulos 2007 Prevention of membrane damage in patient on peritoneal dialysis with new peritoneal dialysis solutions Int Urol Nephrol 39 299 312 10.1007/s11255-006-9064-y (Pubitemid 46722980)